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The colistin-containing SuperPolymyxin medium was developed for screening polymyxin-resistant Gram-negative bacteria. It
was evaluated with 88 polymyxin-susceptible or polymyxin-resistant cultured Gram-negative isolates. Its sensitivity and speci-
ﬁcity of detection were ca. 100%. The SuperPolymyxin medium is the ﬁrst screening medium that is able to detect intrinsic and
acquired polymyxin-resistant bacteria.
Emergence of polymyxin resistance (PR) is increasingly ob-served among Gram-negative bacteria (1). The identiﬁcation
of the plasmid-mediated colistin resistance determinantMCR-1 is
an additional source of concern (2). Therefore, an early detection
of carriers of PR isolates is becoming important.
Polymyxin-containing culture media are known for screening
intrinsic PR bacterial species, such as Serratia marcescens and
Burkholderia cepacia (3, 4). Those media containing high concen-
trations of colistin are not adapted for screening isolates with ac-
quired PR that may be of a low level and may contain deoxycholic
acids that may interfere with the growth of PR bacteria (18).
Therefore, our aim was to develop a selective culture medium
for screening any type of PR Gram-negative bacteria. The design
of this medium took into account the necessity to avoid swarming
of Proteus spp. (naturally PR) and to prevent contamination by
Gram-positive bacteria and fungi. The optimal screening medium
retained was based on the eosin methylene blue (EMB) medium
(product no. 70186; EMBFluka, St. Louis,MO,USA) (5), which is
selective for Gram-negative bacteria. This medium may also con-
tribute to species identiﬁcation by differentiating lactose ferment-
ers (dark blue-brown colonies) from nonfermenters (colorless or
light lavender) (Fig. 1). Moreover, differentiation of lactose fer-
menters was possible with Escherichia coli colonies displaying a
characteristic metallic green sheen (Fig. 1A) and Enterobacter spp.
and Klebsiella spp. giving brown, dark-centered, and mucoid col-
onies (Fig. 1B). The optimal colistin (Sigma-Aldrich, St. Louis,
MO, USA) concentration was retained at 3.5 g/ml. Since some
Streptococcus and Staphylococcus strains may still grow on EBM
medium, daptomycin (Novartis,Horsham,UnitedKingdom)was
added at a concentration of 10 g/ml. It is noteworthy that dap-
tomycin and not vancomycin was added since vancomycin poten-
tiates the activity of colistin against severalGram-negative bacteria
(6, 7). Amphotericin B (Bristol-Myers Squibb, Rueil-Malmaison,
France) was also added as an anti-fungi molecule at a concentra-
tion of 5 g/ml.
The stock solutions of colistin, daptomycin, and amphotericin
B were prepared as indicated in Table 1 and may be kept at20°C
for 1 year. Notably, glass tubes were used to prepare colistin stock
solutions to avoid its binding to polystyrene. Colistimethate sul-
fate, a therapeutic prodrug of colistin, cannot be used. The diluted
powder of EMB was autoclaved at 121°C for 15 min. After cooling
FIG 1 Polymyxin-resistant lactose-positive E. coli (A), polymyxin-resistant K. pneumoniae (B), polymyxin-resistant lactose-negative E. coli (C), and a mix of a
heavy inoculum of P. mirabilis and a low inoculum of polymyxin-resistant K. pneumoniae (C) growing on the SuperPolymyxin medium.
TABLE 1 Preparation of the SuperPolymyxin medium
Compound Stock solution (mg/ml)
Quantity or vol
to adda
Final
concnb
EMB agar powder 15 g 3.75%
Distilled water 400 ml
Colistin sulfate 20 In water in glass tubes 70 l 3.5
Daptomycin 20 In water 200 l 10
Amphotericin B 20 In D-()-glucose 10% 100 l 5
a The volume of 400 ml of SuperPolymyxin medium was for, i.e., 20 plates.
b Concentrations are in micrograms per milliliter unless noted otherwise.
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TABLE 2 MICs of polymyxins for the studied strains and limits of detection of the SuperPolymyxin culture medium
Straina Species Origin
MICb
Polymyxin
resistancec
Mechanism of polymyxin
resistance
Lowest
detection
limit
(CFU/ml)d
Lowest
detection
limit in stools
(CFU/ml)dColistin Polymyxin B
Yeast isolates
FR-A C. albicans France NA NA NA NA 107 ND
Gram-positive
cocci isolates
FR-B S. aureus France NA NA NA NA 107 ND
FR-C Staphylococcus
epidermidis
France NA NA NA NA 107 ND
FR-D Enterococcus faecium France NA NA NA NA 107 ND
FR-E Enterococcus faecalis France NA NA NA NA 107 ND
Gram-negative rod
isolates
naturally
resistant to
polymyxins
FR-01 M. morganii France 128 128 R Intrinsic 101 101
FR-02 P. mirabilis France 128 128 R Intrinsic 101 ND
FR-03 Proteus vulgaris France 128 128 R Intrinsic 101 ND
FR-04 Providencia stuartii France 128 128 R Intrinsic 101 ND
FR-05 S. marcescens France 128 128 R Intrinsic 101 ND
FR-201 B. cepacia France 128 128 R Intrinsic 101e ND
FR-202 Burkholderia gladioli France 128 128 R Intrinsic 101 ND
Gram-negative rod
isolates with
an acquired
mechanism of
resistance to
polymyxins
FR-06 K. pneumoniae France 32 64 R PmrA G53C 101 101
FR-07 K. pneumoniae France 32 32 R PmrA G53S 101 101
FR-09 K. pneumoniae Turkey 32 64 R PmrB L17Q 101 101
FR-10 K. pneumoniae South Africa 16 8 R PmrB T157P 101 101
FR-17 K. pneumoniae Turkey 128 128 R PhoQ R16C 101 101
FR-21 K. pneumoniae France 32 64 R MgrB N42Y/K43I 101 101
FR-30 K. pneumoniae France 128 64 R MgrB truncated 101 101
FR-31 K. pneumoniae France 64 32 R MgrB truncated 101 ND
FR-36 K. pneumoniae Colombia 128 128 R MgrB truncated 101 ND
FR-40 K. pneumoniae France 64 64 R MgrB ISEcp1-blaCTX-M-15 10
1 101
FR-41 K. pneumoniae France 128 128 R MgrB IS102-like 101 ND
FR-47 K. pneumoniae Turkey 64 32 R MgrB I3903b-like 101 ND
FR-48 K. pneumoniae Spain 128 128 R MgrB IS903-like 101 ND
FR-49 K. pneumoniae France 64 32 R MgrB IS5-like 101 ND
FR-54 K. pneumoniae Colombia 128 128 R MgrB ISKpn13 101 101
FR-56 K. pneumoniae Spain 64 64 R MgrB ISKpn26 101 ND
FR-68 K. pneumoniae Colombia 64 64 R MgrB ISKpn14 101 101
FR-70 K. pneumoniae Colombia 128 128 R mgrB promoter IS10R 101 ND
FR-71 K. pneumoniae Turkey 32 32 R mgrB promoter ISKpn14 101 ND
FR-86 K. pneumoniae Spain 64 64 R mgrB deletion nt 100 102 ND
FR-89 K. pneumoniae Colombia 128 128 R mgrB deletion nt 23 to 33 101 ND
FR-92 K. oxytoca Colombia 64 64 R mgrB promoter ISKpn26-like 101 101
FR-93 E. coli France 4 4 R Plasmid-mediated mcr-1 gene 102 101
FR-94 E. coli South Africa 16 16 R Plasmid-mediated mcr-1 gene 101 101
FR-98 E. coli South Africa 8 8 R Plasmid-mediated mcr-1 gene 101 ND
FR-203 A. baumannii Switzerland 128 128 R PmrB G260D 102 101
FR-100 K. pneumoniae France 64 64 R Unknown 101 101
FR-102 K. pneumoniae France 32 32 R Unknown 101 ND
FR-113 K. pneumoniae France 128 128 R Unknown 101 ND
FR-114 K. pneumoniae Colombia 64 128 R Unknown 101 ND
FR-116 K. pneumoniae France 64 32 R Unknown 101 ND
FR-119 E. coli France 8 4 R Unknown 101 ND
FR-120 E. coli France 8 4 R Unknown 101 101
FR-121 E. coli France 4 4 R Unknown 101 ND
(Continued on following page)
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the EMB medium for 1 h at 56°C, the antibiotic stock solutions
were added. Poured plates were stored at 4°C, protected from
direct light exposure for up to 1 week.
A total of 88 isolates were included in the study to evaluate the
performance of the SuperPolymyxin medium that included 52 PR
Gram-negative bacteria of worldwide origin (Table 2). Seven
strains were intrinsic PR genders (Morganella, Proteus, Providen-
cia, Serratia, and Burkholderia). Forty-ﬁve isolates with acquired
PR were also included and consisted of 36 enterobacterial strains
(E. coli, Klebsiella spp., Enterobacter cloacae, and Hafnia alvei) and
9 nonfermenters (Acinetobacter baumannii, Pseudomonas aerugi-
nosa, and Stenotrophomonas maltophilia). Thirty-one polymyxin-
susceptible strains were included with 23 enterobacterial strains
and 8 nonfermenters (Table 2).
MICs of polymyxins (colistin and polymyxin B) were deter-
mined using the broth microdilution method in cation-adjusted
TABLE 2 (Continued)
Straina Species Origin
MICb
Polymyxin
resistancec
Mechanism of
polymyxin resistance
Lowest
detection
limit
(CFU/ml)d
Lowest
detection
limit in stools
(CFU/ml)dColistin Polymyxin B
FR-122 E. cloacae Colombia 32 16 R Unknown 101 101
FR-126 E. cloacae France 128 128 R Unknown 101 102
FR-135 H. alvei France 16 8 R Unknown 101 101
FR-204 A. baumannii USA 128 128 R Unknown 102 101
FR-205 A. baumannii USA 8 8 R Unknown 102 ND
FR-206 A. baumannii USA 128 128 R Unknown 102 ND
FR-207 P. aeruginosa Colombia 64 64 R Unknown 102f 101
FR-208 P. aeruginosa France 128 128 R Unknown 101e ND
FR-209 P. aeruginosa France 128 128 R Unknown 102f ND
FR-210 S. maltophilia France 128 128 R Unknown 101e ND
FR-211 S. maltophilia France 32 32 R Unknown 5.102e ND
Gram-negative rod
isolates
susceptible to
polymyxins
FR-136 E. coli ATCC 25922 0.25 0.25 S NA 107 ND
FR-212 E. coli USA 0.12 0.12 S NA 107 ND
FR-213 E. coli Colombia 0.12 0.12 S NA 107 ND
FR-214 E. coli France 0.12 0.12 S NA 107 ND
FR-215 E. coli France 0.25 0.12 S NA 107 ND
FR-216 E. coli France 0.25 0.12 S NA 107 ND
FR-217 K. pneumoniae USA 0.12 0.12 S NA 5 106 ND
FR-218 K. pneumonia Colombia 0.12 0.5 S NA 107 ND
FR-219 K. pneumoniae Colombia 0.12 0.12 S NA 107 ND
FR-220 K. pneumoniae Colombia 0.5 0.25 S NA 5 106 ND
FR-221 K. pneumoniae Colombia 0.5 0.5 S NA 107 ND
FR-222 K. pneumoniae France 0.12 0.25 S NA 107 ND
FR-223 K. pneumoniae France 0.12 0.12 S NA 106 ND
FR-224 K. pneumoniae France 0.25 0.5 S NA 106 ND
FR-225 K. pneumoniae France 0.5 0.5 S NA 107 ND
FR-226 K. pneumoniae Spain 0.5 0.5 S NA 106 ND
FR-227 K. pneumoniae Spain 0.5 0.5 S NA 107 ND
FR-228 E. cloacae Colombia 0.12 0.25 S NA 107 ND
FR-229 E. cloacae Colombia 0.12 0.12 S NA 107 ND
FR-230 E. cloacae France 0.12 0.25 S NA 5 106 ND
FR-231 Enterobacter
aerogenes
France 0.12 0.12 S NA 107 ND
FR-232 Citrobacter freundii Colombia 0.25 0.25 S NA 107 ND
FR-233 C. freundii France 0.12 0.5 S NA 5 106 ND
FR-234 P. aeruginosa ATCC 27853 0.5 0.5 S NA 5 106 ND
FR-235 P. aeruginosa Colombia 1 0.25 S NA 107 ND
FR-236 P. aeruginosa Colombia 2 0.5 S NA 106 ND
FR-237 P. aeruginosa Colombia 1 0.25 S NA 107 ND
FR-238 P. aeruginosa France 2 0.25 S NA 106 ND
FR-239 A. baumannii Colombia 0.5 0.12 S NA 107 ND
FR-240 A. baumannii France 0.5 0.25 S NA 106 ND
FR-241 A. baumannii USA 0.25 0.25 S NA 106 ND
a The strains FR-01 and FR-136 were used as positive and negative controls, respectively.
b MICs of colistin and polymyxin B were determined using the broth microdilution method. NA, not available.
c R, resistant; S, susceptible.
d Underlined CFU counts are considered to be results below cutoff values set at1 103 CFU/ml. ND, not determinate.
e Positive culture after 36 h.
f Positive culture after 48 h.
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Mueller-Hinton broth as recommended by the CLSI (8). A ﬁnal
inoculum of 5 105 CFU/ml of each strain was distributed in the
96-polystyrene-well tray (Sarstedt, Nümbrecht, Germany). E. coli
ATCC 25922 and P. aeruginosa ATCC 27853 were used as poly-
myxin-susceptible control strains (9), and all experiments were
repeated in triplicate. The results were interpreted according to
the CLSI breakpoints (9) for A. baumannii (susceptible [S], 2
g/ml; resistant [R],4g/ml) and for Pseudomonas spp. (S,2
g/ml; R,8 g/ml) and according to the EUCAST breakpoints
for Enterobacteriaceae (i.e., S,2 g/ml; R,2 g/ml) (10). MIC
values for colistin and polymyxin B were superimposable, permit-
ting an easy classiﬁcation between PR and polymyxin-susceptible
strains (Table 2).
The known genes possibly involved in chromosomally en-
coded PR in E. coli, Klebsiella pneumoniae, Klebsiella oxytoca, P.
aeruginosa, and A. baumannii were sequenced as described previ-
ously (11–15). The PCR detection of the mcr-1 gene was carried
out as described previously (2) (Table 2). MIC values of polymyx-
ins for strains with acquired resistance were variable and were
lower than those for intrinsically PR strains (Table 2).
Using an inoculum with an optical density of 0.5 McFarland
standard (inoculum of108 CFU/ml), serial 10-fold dilutions of
the isolates were made in normal saline, and 100-l portions were
plated onto the SuperPolymyxin medium. To quantify the viable
bacteria in each dilution, Trypticase soy agar was inoculated con-
comitantlywith 100l of suspension andwas incubated overnight
at 37°C. The number of viable colonies was counted after 24 h of
culture at 37°C (and after 36 and 48 h for B. cepacia, P. aeruginosa,
and S. maltophilia). PR and polymyxin-susceptible control strains
were FR-01 (Morganella morganii) and FR-136 (E. coli ATCC
25922), respectively (Table 2). The lowest limit of detection for the
tested strainswas determined using the SuperPolymyxinmedium.
The sensitivity and speciﬁcity cutoff values were set at 1  103
CFU/ml, i.e., a limit value of 1  103 CFU/ml and above was
considered not efﬁciently detected (16). All of the PR strains grew
on the SuperPolymyxin medium in 24 h except P. aeruginosa, S.
maltophilia, and the intrinsically PR Burkholderia genus that grew
in 24 to 48 h (Table 2). The lowest limit of detection was below the
cutoff value for all PR strains, whereas the limit of detection of the
polymyxin-susceptible strains was above the cutoff value at1
106 CFU/ml (Table 1). The sensitivity and speciﬁcity of the Super-
Polymyxin medium for selecting PR isolates were 100% in both
cases. Moreover, this medium was tested with a light growth of a
PR K. pneumoniae isolate (FR-10) among a heavier growth of
Proteus mirabilis (FR-02) and revealed that it nicely discriminated
between the two species (Fig. 1D).
Spiked stools were also tested with a representative collection
of 22 PR isolates of various species with various levels and mech-
anisms of PR (Table 2). Spiked fecal samples were made by adding
100l of each strain dilution to 900l of fecal suspension that was
obtained by suspending 5 g of freshly pooled feces from ﬁve
healthy volunteers in 50 ml of distilled water as described previ-
ously (17). A nonspiked fecal suspension was used as a negative
control. The lowest detection limit of the PR isolate was deter-
mined by plating 100 l of each dilution on the medium. The
sensitivity and speciﬁcity were determined using the same cutoff
value set at 103 CFU/ml (17). This value may correspond to a
low-level carriage of PR bacteria in stools. All of the PR isolates
spiked in stools grew with a lowest detection limit ranging from
101 to 102 CFU/ml (Table 2).
Similar results were obtained with 20 colistin-susceptible and
polymyxin B-susceptible strains and 20 colistin-resistant and
polymyxin B-resistant strains by using polymyxin B at the same
concentration instead of colistin sulfate.
Finally, to assess the storage stability of the SuperPolymyxin
medium, Candida albicans, Staphylococcus aureus, and colistin-
susceptible E. coli ATCC 25955 were subcultured daily onto
SuperPolymyxin agar plates from a single batch of medium stored
at 4°C. Growth of those isolates were consistently inhibited during
at least a 7-day period.
The SuperPolymyxin medium constitutes a screening medium
aimed to detect any PR bacteria regardless of its resistance mech-
anism and of its level. This medium may be used in human med-
icine for detecting carriers and in veterinary medicine for surveil-
lance surveys.
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